| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
kininogen 1 | 0.481 | 0.885 | 3.2E-10 |
|
phenotype | 0.300 | None | 1.000 | 7 | 0 | 1986 | 2018 | ||||||||
|
transient receptor potential cation channel subfamily V member 1 | 0.446 | 0.885 | 1.0E-16 |
|
phenotype | 0.300 | None | 1.000 | 4 | 0 | 2006 | 2012 | ||||||||
|
proopiomelanocortin | 0.356 | 0.846 | 1.2E-04 |
|
phenotype | 0.300 | None | 1.000 | 3 | 0 | 1972 | 2010 | ||||||||
|
colony stimulating factor 3 | 0.377 | 0.885 | 0.38 |
|
phenotype | 0.300 | None | 1.000 | 3 | 0 | 1995 | 2000 | ||||||||
|
tachykinin precursor 1 | 0.424 | 0.923 | 0.75 |
|
phenotype | 0.300 | None | 1.000 | 3 | 0 | 1993 | 2009 | ||||||||
|
prodynorphin | 0.535 | 0.577 | 1.7E-04 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2007 | 2010 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2008 | 2010 | ||||||||
|
histamine receptor H1 | 0.647 | 0.654 | 1.9E-06 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2002 | 2003 | ||||||||
|
endothelin 1 | 0.380 | 0.846 | 0.46 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2009 | 2010 | ||||||||
|
arginine vasopressin | 0.437 | 0.846 | 7.4E-02 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 1984 | 1990 | ||||||||
|
oxytocin/neurophysin I prepropeptide | 0.615 | 0.423 | 0.71 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 1984 | 2007 | ||||||||
|
opioid receptor kappa 1 | 0.555 | 0.615 | 4.1E-05 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 1998 | 1998 | ||||||||
|
neurotensin receptor 1 | 0.563 | 0.692 | 1.9E-08 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
natriuretic peptide receptor 1 | 0.608 | 0.654 | 2.9E-04 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
natriuretic peptide B | 0.513 | 0.808 | 9.9E-06 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
natriuretic peptide A | 0.505 | 0.769 | 5.5E-04 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
vasoactive intestinal peptide | 0.437 | 0.846 | 4.2E-04 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 1998 | 1998 | ||||||||
|
proenkephalin | 0.560 | 0.808 | 2.1E-04 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
prepronociceptin | 0.603 | 0.577 | 1.5E-02 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
5-hydroxytryptamine receptor 3B | 0.678 | 0.423 | 2.5E-07 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
transient receptor potential cation channel subfamily A member 1 | 0.546 | 0.846 | 7.2E-35 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
bradykinin receptor B2 | 0.585 | 0.808 | 0.12 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
solute carrier family 9 member A1 | 0.550 | 0.731 | 0.79 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
calcium voltage-gated channel auxiliary subunit alpha2delta 1 | 0.641 | 0.500 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
prokineticin receptor 1 | 0.861 | 0.192 | 1.2E-07 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2006 | 2006 |